BioCentury
ARTICLE | Clinical News

Cytokinetics, GlaxoSmithKline preclinical data

October 27, 2008 7:00 AM UTC

In mouse xenograft models of advanced colon cancer, animals receiving 125 mg/kg of GSK-923295 had a 6% decrease in tumor volume during the first treatment cycle while those receiving 62.5 mg/kg had a ...